About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pulsed Perfusion for Marginal Kidneys | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT02055950

Pulsed Perfusion for Marginal Kidneys

Trends in organ donor pool are characterized by an increasing age and a shift towards cerebrovascular diseases as primary causes of death. As a result, donors older than 60 years nowadays represent mo...

Lead sponsor: Mario Negri Institute for Pharmacological Research•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Mario Negri Institute for Pharmacological Research

Collaborators

Fondazione IRCCS Policlinico San Matteo di Pavia

Age

50 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Males and females aged 50 years or more and no more than 10 years older or younger than their corresponding donors;
•First single or double kidney transplant from deceased donors older than 60 years;
•Pre-implantation histologic evaluation and graft selection and allocation based on the histologic score and according to the Nord Italian Transplant (NIT) criteria;
•Written informed consent.

Exclusion Criteria

•Any factor that according to the NIT selection criteria represent a contraindication to receive a deceased donor kidney transplant
•Need for specific de-sensitization protocols because of high immunological risk (according to NIT criteria) or participation in other concomitant intervention studies
•Vascular abnormalities/changes that preclude the possibility to perfuse the kidney grafts by a pulsatile machine

Related studies

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

Effects of Replacing High Protein Foods in People With Chronic Kidney Disease

NCT07105670 · Chronic Kidney Disease Stage 3

A Natural History Study of Metabolic Sizing in Health and Disease

NCT05398783 · Metabolic Disorders, Cancer, and more

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 4, 2018Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment60

Start dateJul 2013

Last updatedSep 4, 2018

Condition

Chronic Kidney Disease

Locations shown

A.O. Papa Giovanni XXIII - U.O. Nefrologia e Dialisi/U.O. Chirurgia Pediatrica

Bergamo

IRCCS Policlinico S.Matteo - UOS trapianto di Rene/U.O. Nefrologia

Pavia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 4, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions